Molecular Signal Transduction Laboratory, Cancer Pharmacology Division, Indian Institute of Integrative Medicine (CSIR), Jammu Tawi, India.
PLoS One. 2012;7(9):e44039. doi: 10.1371/journal.pone.0044039. Epub 2012 Sep 4.
Withaferin A, which is a naturally derived steroidal lactone, has been found to prevent angiogenesis and metastasis in diverse tumor models. It has also been recognized by different groups for prominent anti-carcinogenic roles. However, in spite of these studies on withanolides, their detailed anti-metastatic mechanism of action remained unknown. The current study has poised to address the machinery involved in invasion regulation by stable derivative of Withaferin A, 3-azido Withaferin A (3-azidoWA) in human cervical HeLa and prostate PC-3 cells.
Sub-toxic concentration of 3-azidowithaferin A (3-azido WA) inhibited cancer cell motility and invasion in wound healing and Boyden chamber invasion by suppressing MMP-2 activity in gelatin zymography and its expression has proved to be a major obstacle in chemo-sensitivity. We have uncovered a novel mechanism of 3-azidoWA induced extracellular pro-apoptotic candidate tumor suppressor Par-4 protein stimulation in conditioned media and also noticed a concomitant marked reduction in pAkt and pERK signaling by immunoblot analysis. Furthermore, our zymography results suggest 3-azidoWA induced MMP-2 inhibition was mediated through secretory Par-4. The inhibition of apoptosis by 3-azidoWA could not restore MMP-2 gelatinase activity. In addition to this, our in vivo animal experiments data showed 3-azidoWA abrogated neovascularisation in dose dependent manner in mouse Matrigel plug assay.
CONCLUSION/SIGNIFICANCE: For this report, we found that 3-azidoWA suppressed motility and invasion of HeLa and PC-3 cells in MMP-2 dependent manner. Our in vitro result strongly suggests that sub-toxic doses of 3-azidoWA enhanced the secretion of extracellular Par-4 that abolished secretory MMP-2 expression and activity. Depletion of secretory Par-4 restored MMP-2 expression and invasion capability of HeLa and PC-3 cells. Further, our findings implied that 3-azidoWA attenuated internal phospho-ERK and phospho-Akt expression in a dose dependent manner might play a key role in inhibition of mouse angiogenesis by 3-azidoWA.
Withaferin A 是一种天然衍生的甾体内酯,已被发现可防止多种肿瘤模型中的血管生成和转移。不同的研究小组也认识到它具有显著的抗癌作用。然而,尽管有这些关于 Withanolides 的研究,但它们的详细的抗转移作用机制仍然未知。本研究旨在研究稳定衍生物 3-叠氮 Withaferin A(3-azidoWA)在人宫颈 HeLa 和前列腺 PC-3 细胞中对侵袭调控的机制。
亚毒性浓度的 3-叠氮 Withaferin A(3-azidoWA)通过抑制明胶酶谱中的 MMP-2 活性及其表达,抑制了癌细胞的迁移和侵袭,在伤口愈合和 Boyden 室侵袭实验中,这被证明是化疗敏感性的主要障碍。我们发现了一种新的机制,即 3-azidoWA 诱导细胞外促凋亡候选肿瘤抑制因子 Par-4 蛋白在条件培养基中的刺激,并通过免疫印迹分析注意到伴随的 pAkt 和 pERK 信号的显著减少。此外,我们的酶谱结果表明,3-azidoWA 诱导的 MMP-2 抑制是通过分泌性 Par-4 介导的。3-azidoWA 对凋亡的抑制不能恢复 MMP-2 明胶酶活性。除此之外,我们的体内动物实验数据表明,3-azidoWA 以剂量依赖的方式在小鼠 Matrigel plugs 实验中阻断新生血管形成。
结论/意义:对于本报告,我们发现 3-azidoWA 以 MMP-2 依赖的方式抑制 HeLa 和 PC-3 细胞的迁移和侵袭。我们的体外结果强烈表明,亚毒性剂量的 3-azidoWA 增强了细胞外 Par-4 的分泌,从而消除了分泌性 MMP-2 的表达和活性。分泌性 Par-4 的耗竭恢复了 HeLa 和 PC-3 细胞的 MMP-2 表达和侵袭能力。此外,我们的研究结果表明,3-azidoWA 以剂量依赖的方式减弱了内部磷酸化 ERK 和磷酸化 Akt 的表达,这可能在 3-azidoWA 抑制小鼠血管生成中发挥关键作用。